3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Sarcoma
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Multiple Myeloma
2
Leukemia, Myeloid, Acute
2
Carcinoma, Hepatocellular
2
Advanced Solid Tumors
2
Advanced Endometrial Cancer
2
Thrombosis
1
Thrombophilia
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Resectable Esophageal Squamous Cell Carcinoma
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroma
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Interventions
enoxaparin sodium
1
Observation
1
Injections
1
Dalteparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Thrombophilia
×
Injections
×
Clear all
NCT06153394
2024-04-23
PRIORITY
Western University, Canada
Phase 3
Not yet recruiting
50 enrolled